Foghorn Therapeutics
(NASDAQ:FHTX)
$6.07
0.51[9.17%]
Last update: 11:14AM Get Real Time Here
Q1 2024 Earnings were released on Mon May 6th, before the market open
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Foghorn Therapeutics Stock (NASDAQ:FHTX), Quotes and News Summary

Foghorn Therapeutics Stock (NASDAQ: FHTX) stock price, news, charts, stock research, profile.

Open$5.630
Close-
Volume / Avg.4.394K / 112.830K
Day Range5.630 - 6.060
52 Wk Range2.700 - 9.970
Market Cap$258.495M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
52
Short Interest
4.08%
Days to Cover15.9

Recent News

Why Foghorn Therapeutics (FHTX) Stock Is Exploding Higher
Foghorn Therapeutics shares are trading higher by 44.8% Thursday. The company announced that Eli Lilly has chosen FHD-909 for clinical development.
Henry Khederian
Why Cineverse Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Addentax Group Corp. (NASDAQ: ATXG) shares jumped 47.3% to $9.68. Addentax Group is launching automation of artificial intelligence internet operational tools project with top Games-as-a-Service firms.
Lisa Levin
Schrödinger To Rally Around 14%? Here Are 10 Other Analyst Forecasts For Thursday
Keybanc boosted the price target for Micron Technology, Inc. (NASDAQ: MU) from $70 to $80. Keybanc analyst John Vinh maintained an Overweight rating. Micron shares rose 3.9% to $69.70 in pre-market trading.
Lisa Levin
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Mar
2
Apr
2
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.6
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
FHTX
AGEN

FAQ

Q

How do I buy Foghorn Therapeutics (FHTX) stock?

A

You can purchase shares of Foghorn Therapeutics (NASDAQ: FHTX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Foghorn Therapeutics's (FHTX) competitors?

A

Other companies in Foghorn Therapeutics’s space includes: Agenus (NASDAQ:AGEN), Monte Rosa Therapeutics (NASDAQ:GLUE), Century Therapeutics (NASDAQ:IPSC), Design Therapeutics (NASDAQ:DSGN) and Emergent BioSolutions (NYSE:EBS).

Q

What is the target price for Foghorn Therapeutics (FHTX) stock?

A

The latest price target for Foghorn Therapeutics (NASDAQ: FHTX) was reported by HC Wainwright & Co. on Tuesday, May 7, 2024. The analyst firm set a price target for 20.00 expecting FHTX to rise to within 12 months (a possible 229.49% upside). 11 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Foghorn Therapeutics (FHTX)?

A

The stock price for Foghorn Therapeutics (NASDAQ: FHTX) is $6.07 last updated Today at May 13, 2024 at 11:14 AM EDT.

Q

Does Foghorn Therapeutics (FHTX) pay a dividend?

A

There are no upcoming dividends for Foghorn Therapeutics.

Q

When is Foghorn Therapeutics (NASDAQ:FHTX) reporting earnings?

A

Foghorn Therapeutics’s Q2 earnings are confirmed for Friday, August 2, 2024.

Q

Is Foghorn Therapeutics (FHTX) going to split?

A

There is no upcoming split for Foghorn Therapeutics.

Q

What sector and industry does Foghorn Therapeutics (FHTX) operate in?

A

Foghorn Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch